Literature DB >> 22030714

Novel therapeutic strategies for alcohol and drug addiction: focus on GABA, ion channels and transcranial magnetic stimulation.

Giovanni Addolorato1, Lorenzo Leggio, F Woodward Hopf, Marco Diana, Antonello Bonci.   

Abstract

Drug addiction represents a major social problem where addicts and alcoholics continue to seek and take drugs despite adverse social, personal, emotional, and legal consequences. A number of pharmacological compounds have been tested in human addicts with the goal of reducing the level or frequency of intake, but these pharmacotherapies have often been of only moderate efficacy or act in a sub-population of humans. Thus, there is a tremendous need for new therapeutic interventions to treat addiction. Here, we review recent interesting studies focusing on gamma-aminobutyric acid receptors, voltage-gated ion channels, and transcranial magnetic stimulation. Some of these treatments show considerable promise to reduce addictive behaviors, or the early clinical studies or pre-clinical rationale suggest that a promising avenue could be developed. Thus, it is likely that within a decade or so, we could have important new and effective treatments to achieve the goal of reducing the burden of human addiction and alcoholism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22030714      PMCID: PMC3238087          DOI: 10.1038/npp.2011.216

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  207 in total

1.  T-type calcium channel antagonism decreases motivation for nicotine and blocks nicotine- and cue-induced reinstatement for a response previously reinforced with nicotine.

Authors:  Jason M Uslaner; Joshua D Vardigan; Jason M Drott; Victor N Uebele; John J Renger; Ariel Lee; Zhaoxia Li; A D Lê; Pete H Hutson
Journal:  Biol Psychiatry       Date:  2010-07-01       Impact factor: 13.382

Review 2.  T-type calcium channels inhibitors: a patent review.

Authors:  Fabrizio Giordanetto; Laurent Knerr; Andreas Wållberg
Journal:  Expert Opin Ther Pat       Date:  2010-11-19       Impact factor: 6.674

Review 3.  Turning the clock ahead: potential preclinical and clinical neuropharmacological targets for alcohol dependence.

Authors:  Lorenzo Leggio; Silvia Cardone; Anna Ferrulli; George A Kenna; Marco Diana; Robert M Swift; Giovanni Addolorato
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

4.  Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents.

Authors:  M J Field; R J Oles; A S Lewis; S McCleary; J Hughes; L Singh
Journal:  Br J Pharmacol       Date:  1997-08       Impact factor: 8.739

5.  Double-blind randomized controlled trial of baclofen vs. clonidine in the treatment of opiates withdrawal.

Authors:  S Akhondzadeh; S A Ahmadi-Abhari; S M Assadi; O L Shabestari; A R Kashani; Z M Farzanehgan
Journal:  J Clin Pharm Ther       Date:  2000-10       Impact factor: 2.512

6.  Effects of verapamil, an antagonist of L-type calcium channels, on cardiovascular symptoms in alcohol withdrawal.

Authors:  Seppo Kähkönen; Boris B Bondarenko; Jari Lipsanen; Edwin E Zvartau
Journal:  Neuropsychobiology       Date:  2008-11-08       Impact factor: 2.328

7.  Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat.

Authors:  Paola Fadda; Maria Scherma; Alessandra Fresu; Maria Collu; Walter Fratta
Journal:  Synapse       Date:  2003-10       Impact factor: 2.562

8.  L-type calcium channel blockade attenuates morphine withdrawal: in vivo interaction between L-type calcium channels and corticosterone.

Authors:  Saeed Esmaeili-Mahani; Yadollah Fathi; Fereshteh Motamedi; Farhad Hosseinpanah; Abolhassan Ahmadiani
Journal:  Horm Behav       Date:  2007-11-13       Impact factor: 3.587

9.  Acute interaction of baclofen in combination with alcohol in heavy social drinkers.

Authors:  Suzette M Evans; Adam Bisaga
Journal:  Alcohol Clin Exp Res       Date:  2008-10-06       Impact factor: 3.455

10.  Effects of nimodipine and other calcium channel antagonists in alcohol-preferring AA rats.

Authors:  R De Beun; R Schneider; A Klein; A Lohmann; J De Vry
Journal:  Alcohol       Date:  1996 May-Jun       Impact factor: 2.405

View more
  36 in total

1.  Neurotherapeutics.

Authors:  Gwenn S Smith; Xiaohua Li; P Jeffrey Conn
Journal:  Neuropsychopharmacology       Date:  2012-01       Impact factor: 7.853

Review 2.  Behavioral and Genetic Evidence for GIRK Channels in the CNS: Role in Physiology, Pathophysiology, and Drug Addiction.

Authors:  Jody Mayfield; Yuri A Blednov; R Adron Harris
Journal:  Int Rev Neurobiol       Date:  2015-06-22       Impact factor: 3.230

3.  Glutamatergic and GABAergic susceptibility loci for heroin and cocaine addiction in subjects of African and European ancestry.

Authors:  Orna Levran; Einat Peles; Matthew Randesi; Joel Correa da Rosa; Jurg Ott; John Rotrosen; Miriam Adelson; Mary Jeanne Kreek
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-08-12       Impact factor: 5.067

Review 4.  Proteomic approaches and identification of novel therapeutic targets for alcoholism.

Authors:  Giorgio Gorini; R Adron Harris; R Dayne Mayfield
Journal:  Neuropsychopharmacology       Date:  2013-07-31       Impact factor: 7.853

Review 5.  Pharmacological and psychosocial management of mental, neurological and substance use disorders in low- and middle-income countries: issues and current strategies.

Authors:  Jair de Jesus Mari; Luís Fernando Tófoli; Cristiano Noto; Li M Li; Alessandra Diehl; Angélica M Claudino; Mario F Juruena
Journal:  Drugs       Date:  2013-09       Impact factor: 9.546

Review 6.  Neurochemical and neurostructural plasticity in alcoholism.

Authors:  Justin T Gass; M Foster Olive
Journal:  ACS Chem Neurosci       Date:  2012-04-16       Impact factor: 4.418

7.  High frequency deep transcranial magnetic stimulation acutely increases β-endorphins in obese humans.

Authors:  Anna Ferrulli; Concetta Macrì; Ileana Terruzzi; Federico Ambrogi; Valentina Milani; Michela Adamo; Livio Luzi
Journal:  Endocrine       Date:  2018-11-08       Impact factor: 3.633

8.  Genome-wide meta-analysis identifies a novel susceptibility signal at CACNA2D3 for nicotine dependence.

Authors:  Xianyong Yin; Chris Bizon; Jeffrey Tilson; Yuan Lin; Ian R Gizer; Cindy L Ehlers; Kirk C Wilhelmsen
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-04-25       Impact factor: 3.568

9.  Gut microbiota modulates alcohol withdrawal-induced anxiety in mice.

Authors:  Hui-Wen Xiao; Chang Ge; Guo-Xing Feng; Yuan Li; Dan Luo; Jia-Li Dong; Hang Li; Haichao Wang; Ming Cui; Sai-Jun Fan
Journal:  Toxicol Lett       Date:  2018-01-31       Impact factor: 4.372

10.  Corticotropin-releasing factor in the mouse central nucleus of the amygdala: ultrastructural distribution in NMDA-NR1 receptor subunit expressing neurons as well as projection neurons to the bed nucleus of the stria terminalis.

Authors:  Marc A Beckerman; Tracey A Van Kempen; Nicholas J Justice; Teresa A Milner; Michael J Glass
Journal:  Exp Neurol       Date:  2012-10-12       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.